RMD vs TFX · P/E 29, rev $5.65B vs P/E 2083, rev $1.12B
ResMed Inc (RMD) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Latest reported TFX revenue for 2026-06-30 was $1.12B. Net income was $91.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
RMD currently screens at market cap $37.68B and trailing P/E 28.8. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the RMD and TFX stock pages for the full models.
Not investment advice.